Merck Global Health Innovation Fund is a venture capital firm in Whitehouse Station that prefers to invest in emerging healthcare technology companies. Founded 2010 in Whitehouse Station, New Jersey, the firm invests in Series B, Series D, Series C, and Series E rounds. The notable investment portfolio of Merck Global Health Innovation Fund includes PathAI, Navigating Cancer, Ciox Health, and GenomeDx Biosciences. As of January 2020, Merck Global Health Innovation Fund has made 57 investments and 14 exits. Their most recent investment was on Nov 4, 2019, when PathAI raised $15M.
Timeline
People
Dave Stevenson
Managing Director
David M. Rubin
Executive Director
Francesca Domenech Wuttke
Managing Director and Head of Venture Investments
Joe Volpe
Investment Principal
William Taranto
President
Further reading
Documentaries, videos and podcasts
Companies
Ciox Health
ClearDATA
electroCore
Livongo
Navigating Cancer
PathAI
Prognos
Strata Oncology
TriNetX
News
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Jed Christiansen
Special Projects & Business Development at Golden, Founder - Seed-DB. - 3
Joshua Elkington
Axial - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Henry Ogolla
Passionate about reading and writing. - 6
Aime Anne Nisay
QA Engineer of web and mobile applications
